当前位置： SCI文献检索 > CANCER RESEARCH期刊下所有文献 > Human monocytes, but not dendritic cells derived from them, are defective in base excision repair and hypersensitive to methylating agents.

Human monocytes, but not dendritic cells derived from them, are defective in base excision repair and hypersensitive to methylating agents.

Abstract：

:Monocytes and dendritic cells are key players in the immune response. Because dendritic cells drive the tumor host defense, it is important that monocytes and dendritic cells survive cytotoxic tumor therapy. Although most of the anticancer drugs target DNA, the DNA repair capacity of monocytes and dendritic cells has not yet been investigated. We studied the sensitivity of monocytes and monocyte-derived dendritic cells against various genotoxic agents and found monocytes to be more sensitive to overall cell kill and apoptosis upon exposure to methylating agents (e.g., N-methyl-N'-nitro-N-nitrosoguanidine, methyl methanesulfonate, and the anticancer drug temozolomide). On the other hand, upon treatment with the cross-linking chemotherapeutics fotemustine, mafosfamide, and cisplatin, monocytes and dendritic cells responded in the same way. Monocytes were also more sensitive than lymphocytes. The data indicate a defect in the repair of DNA methylation damage in monocytes. Because the expression of the repair protein O(6)-methylguanine-DNA methyltransferase was higher in monocytes than in dendritic cells, and because its inhibition by O(6)-benzylguanine had no effect on the sensitivity of monocytes, we investigated the base excision repair (BER) pathway. In contrast to dendritic cells, monocytes are unable to perform BER following exposure to methylating agents. Expression studies revealed that monocytes lack XRCC1 and ligase IIIalpha, whereas dendritic cells, similar to human lymphocytes, express these repair proteins at a high level. The data revealed a DNA repair defect in a specific human cell population. The BER defect in monocytes may cause them to be selectively killed during tumor therapy with alkylating agents, provoking hematotoxicity and sustained immunosuppression.

journal_name

Cancer Res

journal_title

Cancer research

authors

Briegert M,Kaina B

doi

10.1158/0008-5472.CAN-06-3712

subject

Has Abstract

pub_date

2007-01-01 00:00:00

pages

26-31

issue

eissn

0008-5472

issn

1538-7445

pii

67/1/26

journal_volume

pub_type

杂志文章

在线工具

Human monocytes, but not dendritic cells derived from them, are defective in base excision repair and hypersensitive to methylating agents.